Susan Monarez has previously held several prominent positions within the U.S. government. She served as deputy director of the Advanced Research Projects Agency for Health, where she led initiatives in AI and health technology. She has also held roles at the Department of Homeland Security and the White House Office of Science and Technology Policy. This nomination is notable as Monarez would be the first CDC director to require Senate confirmation, following a law change in 2022.
Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward.
Thomas Payne, HCA Healthcare's national medical director of robotics, explains how the largest U.S. health system is vetting a new crop of market entrants.
Two California researchers say a U.S. government health publication instructed them to remove data on sexual orientation from a scientific manuscript that had been accepted for publication. The researchers also said they were told to remove the words "gender," "cisgender" and "equitable" from their paper, which looked at smoking among rural young adults.
Gene testing firm 23andMe said on Sunday it had filed for Chapter 11 bankruptcy protection in order to facilitate its sale, after years of struggling to find a sustainable business model.